Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DUS2 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | ATP9B | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | MLKL | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
mRNA | PATZ1 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | PHACTR4 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | IQGAP1 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
mRNA | ZNF8 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | ACD | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
mRNA | PCDHA12 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | ADAMTSL2 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |